Literature DB >> 9447963

Sip1, a novel RS domain-containing protein essential for pre-mRNA splicing.

W J Zhang1, J Y Wu.   

Abstract

Previous studies have shown that protein-protein interactions among splicing factors may play an important role in pre-mRNA splicing. We report here identification and functional characterization of a new splicing factor, Sip1 (SC35-interacting protein 1). Sip1 was initially identified by virtue of its interaction with SC35, a splicing factor of the SR family. Sip1 interacts with not only several SR proteins but also with U1-70K and U2AF65, proteins associated with 5' and 3' splice sites, respectively. The predicted Sip1 sequence contains an arginine-serine-rich (RS) domain but does not have any known RNA-binding motifs, indicating that it is not a member of the SR family. Sip1 also contains a region with weak sequence similarity to the Drosophila splicing regulator suppressor of white apricot (SWAP). An essential role for Sip1 in pre-mRNA splicing was suggested by the observation that anti-Sip1 antibodies depleted splicing activity from HeLa nuclear extract. Purified recombinant Sip1 protein, but not other RS domain-containing proteins such as SC35, ASF/SF2, and U2AF65, restored the splicing activity of the Sip1-immunodepleted extract. Addition of U2AF65 protein further enhanced the splicing reconstitution by the Sip1 protein. Deficiency in the formation of both A and B splicing complexes in the Sip1-depleted nuclear extract indicates an important role of Sip1 in spliceosome assembly. Together, these results demonstrate that Sip1 is a novel RS domain-containing protein required for pre-mRNA splicing and that the functional role of Sip1 in splicing is distinct from those of known RS domain-containing splicing factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9447963      PMCID: PMC108778          DOI: 10.1128/MCB.18.2.676

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  78 in total

1.  U1 snRNP targets an essential splicing factor, U2AF65, to the 3' splice site by a network of interactions spanning the exon.

Authors:  B E Hoffman; P J Grabowski
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

2.  Novel delayed-early and highly insulin-induced growth response genes. Identification of HRS, a potential regulator of alternative pre-mRNA splicing.

Authors:  R H Diamond; K Du; V M Lee; K L Mohn; B A Haber; D S Tewari; R Taub
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

Review 3.  Splicing of pre-mRNA: mechanism, regulation and role in development.

Authors:  D C Rio
Journal:  Curr Opin Genet Dev       Date:  1993-08       Impact factor: 5.578

4.  Human SR proteins and isolation of a cDNA encoding SRp75.

Authors:  A M Zahler; K M Neugebauer; J A Stolk; M B Roth
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

5.  Correspondence between a mammalian spliceosome component and an essential yeast splicing factor.

Authors:  M Bennett; R Reed
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

6.  The role of specific protein-RNA and protein-protein interactions in positive and negative control of pre-mRNA splicing by Transformer 2.

Authors:  H Amrein; M L Hedley; T Maniatis
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

7.  Specific interactions between proteins implicated in splice site selection and regulated alternative splicing.

Authors:  J Y Wu; T Maniatis
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

8.  Functional domains of the human splicing factor ASF/SF2.

Authors:  P Zuo; J L Manley
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

9.  Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains.

Authors:  J F Cáceres; A R Krainer
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

10.  Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF.

Authors:  I C Eperon; D C Ireland; R A Smith; A Mayeda; A R Krainer
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  9 in total

1.  The C-terminal region but not the Arg-X-Pro repeat of Epstein-Barr virus protein EB2 is required for its effect on RNA splicing and transport.

Authors:  M Buisson; F Hans; I Kusters; N Duran; A Sergeant
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.

Authors:  Y Cavaloc; C F Bourgeois; L Kister; J Stévenin
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

Review 3.  The role of FUS gene variants in neurodegenerative diseases.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

4.  The SRm160/300 splicing coactivator subunits.

Authors:  B J Blencowe; G Baurén; A G Eldridge; R Issner; J A Nickerson; E Rosonina; P A Sharp
Journal:  RNA       Date:  2000-01       Impact factor: 4.942

5.  Expression of U1 small nuclear ribonucleoprotein 70K antisense transcript using APETALA3 promoter suppresses the development of sepals and petals.

Authors:  Maxim Golovkin; Anireddy S N Reddy
Journal:  Plant Physiol       Date:  2003-08       Impact factor: 8.340

6.  Analysis of mutant phenotypes and splicing defects demonstrates functional collaboration between the large and small subunits of the essential splicing factor U2AF in vivo.

Authors:  Christopher J Webb; Sujata Lakhe-Reddy; Charles M Romfo; Jo Ann Wise
Journal:  Mol Biol Cell       Date:  2004-11-17       Impact factor: 4.138

7.  A novel SR-related protein is required for the second step of Pre-mRNA splicing.

Authors:  Demian Cazalla; Kathryn Newton; Javier F Cáceres
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

8.  Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease.

Authors:  Federica Delunardo; Fabrizio Conti; Paola Margutti; Cristiano Alessandri; Roberta Priori; Alessandra Siracusano; Rachele Riganò; Elisabetta Profumo; Guido Valesini; Maurizio Sorice; Elena Ortona
Journal:  Arthritis Res Ther       Date:  2006-04-12       Impact factor: 5.156

9.  Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems.

Authors:  B Charroux; L Pellizzoni; R A Perkinson; A Shevchenko; M Mann; G Dreyfuss
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.